
[Federal Register Volume 82, Number 2 (Wednesday, January 4, 2017)]
[Notices]
[Pages 850-851]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31847]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-0001]


Advisory Committee; Technical Electronic Product Radiation Safety 
Standards Committee, Renewal

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; renewal of advisory committee.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
renewal of the Technical Electronic Product Radiation Safety Standards 
Committee by the Commissioner of Food and Drugs (the Commissioner). The 
Commissioner has determined that it is in the public interest to renew 
the Technical Electronic Product Radiation Safety Standards Committee 
for an additional 2 years beyond the charter expiration date. The new 
charter will be in effect until December 24, 2018.

DATES: Authority for the Technical Electronic Product Radiation Safety 
Standards Committee will expire on December 24, 2016, unless the 
Commissioner formally determines that renewal is in the public 
interest.

FOR FURTHER INFORMATION CONTACT: Shanika Craig, Center for Devices and 
Radiological Health, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 66, Rm. 1613, Silver Spring, MD, 20993-0002, 301-796-6639, 
Shanika.Craig@fda.hhs.gov

SUPPLEMENTARY INFORMATION: Pursuant to 41 CFR 102-3.65 and approval by 
the Department of Health and Human Services pursuant to 45 CFR part 11 
and by the General Services Administration, FDA is announcing the 
renewal of the Technical Electronic Product Radiation Safety Standards 
Committee. The

[[Page 851]]

committee is a non-discretionary Federal advisory committee established 
to provide advice and consultation to the Commissioner. The 
Commissioner of Food and Drugs is charged with the administration of 
the Radiation Control for Health and Safety Act of 1968. This Act 
creates the Technical Electronic Product Radiation Safety Standards 
Committee and requires the Commissioner to consult with the Committee 
before prescribing standards for radiation emissions from electronic 
products. This Committee provides advice and consultation to the 
Commissioner of Food and Drugs on the technical feasibility, 
reasonableness, and practicability of performance standards for 
electronic products to control the emission of radiation from such 
products, and may recommend electronic product radiation safety 
standards to the Commissioner for consideration.
    The Committee shall consist of a core of 15 voting members 
including the Chair. Members and the Chair are selected by the 
Commissioner or designee from among authorities knowledgeable in the 
fields of science or engineering applicable to electronic product 
radiation safety. Members will be invited to serve for overlapping 
terms of up to 4 years. Terms of more than two years are contingent 
upon the renewal of the Committee by appropriate action prior to its 
expiration. The core of voting members will include five members 
selected from governmental agencies, including State and Federal 
Governments, five members from the affected industries, and five 
members from the general public, of which at least one shall be a 
representative of organized labor. A quorum shall consist of 10 
members, of which at least 3 shall be from the general public, 3 from 
the government agencies, and 3 from the affected industries.
    Further information regarding the most recent charter and other 
information can be found at http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Radiation-EmittingProducts/TechnicalElectronicProductRadiationSafetyStandardsCommittee/default.htm. or by contacting the Designated Federal Officer (see FOR 
FURTHER INFORMATION CONTACT). In light of the fact that no change has 
been made to the committee name or description of duties, no amendment 
will be made to 21 CFR 14.100.
    This document is issued under the Federal Advisory Committee Act (5 
U.S.C. app.). For general information related to FDA advisory 
committees, please visit us at http://www.fda.gov/AdvisoryCommittees/default.htm.

    Dated: December 28, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-31847 Filed 1-3-17; 8:45 am]
 BILLING CODE 4164-01-P


